about
Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic deliveryA structurally biased combinatorial approach for discovering new anti-picornaviral compounds.Avidity mechanism of dendrimer-folic acid conjugates.Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted deliveryLight-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate.Poly(amidoamine) dendrimer-methotrexate conjugates: the mechanism of interaction with folate binding protein.Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate.A photochemical approach for controlled drug release in targeted drug delivery.Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticlesLigand Characteristics Important to Avidity Interactions of Multivalent Nanoparticles.Evaluating binding avidities of populations of heterogeneous multivalent ligand-functionalized nanoparticles.Mechanisms of drug release in nanotherapeutic delivery systems.Atomic force microscopy probing of receptor-nanoparticle interactions for riboflavin receptor targeted gold-dendrimer nanocomposites.A Thioacetal Photocage Designed for Dual Release: Application in the Quantitation of Therapeutic Release by Synchronous Reporter Decaging.Efficacy Dependence of Photodynamic Therapy Mediated by Upconversion Nanoparticles: Subcellular Positioning and Irradiation Productivity.Mechanism of Cooperativity and Nonlinear Release Kinetics in Multivalent Dendrimer-Atropine Complexes.Modular Integration of Upconverting Nanocrystal-Dendrimer Composites for Folate Receptor-Specific NIR Imaging and Light-Triggered Drug Release.Yolk-structured multifunctional up-conversion nanoparticles for synergistic photodynamic-sonodynamic antibacterial resistance therapy.Multivalent dendrimer vectors with DNA intercalation motifs for gene delivery.Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749.A multivalent approach to the discovery of long-acting β(2)-adrenoceptor agonists for the treatment of asthma and COPD.A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery.Light-controlled active release of photocaged ciprofloxacin for lipopolysaccharide-targeted drug delivery using dendrimer conjugatesBioanalytical Screening of Riboflavin Antagonists for Targeted Drug Delivery - A Thermodynamic and Kinetic Study.DNA condensation by partially acetylated poly(amido amine) dendrimers: effects of dendrimer charge density on complex formation.Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.4-Hydroxytamoxifen probes for light-dependent spatiotemporal control of Cre-ER mediated reporter gene expression.Exploring the positional attachment of glycopeptide/beta-lactam heterodimers.Control of an Unusual Photo-Claisen Rearrangement in Coumarin Caged Tamoxifen through an Extended Spacer.Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.Photocontrolled Release of Doxorubicin Conjugated through a Thioacetal Photocage in Folate-Targeted Nanodelivery Systems.The action of philanthotoxin-343 and photolabile analogues on locust (Schistocerca gregaria) muscle.Oritavancin Retains a High Affinity for a Vancomycin-Resistant Cell-Wall Precursor via Its Bivalent Motifs of Interaction.Hydrophilic scaffolds of oxime as the potent catalytic inactivator of reactive organophosphateMonomeric inhibitors of influenza neuraminidase enhance the hemagglutination inhibition activities of polyacrylamides presenting multiple C-sialoside groupsStructure-binding relation of philanthotoxins from nicotinic acetylcholine receptor binding assay
P50
Q26852723-00276F0D-213C-474D-8B82-ECA086714811Q31858092-A3611910-C2E4-44FB-88DF-2CA9A681C634Q33598717-759AEBEA-3786-4CE0-8573-C0534CDBEC91Q33640942-4673929A-1C2A-4C9A-A073-F737A4FD940EQ33983855-1F5166D6-97F3-40A2-B679-2F11EE71F0CBQ34473454-A9A0F1A8-4E61-478C-BA70-F086A042E757Q35624762-BB995C73-50BA-4EA6-9DC4-AB91E47016D0Q35687951-2695CE5F-4FD5-4DA4-8F4E-6B81F89C3B7AQ35688131-E2779954-C583-400A-9A23-1098CD2293B8Q35700348-6301A818-5AF7-4F1D-B9BA-2A4387ADA083Q36702085-F8DAC143-57F2-4B64-A539-A3AC3E6E2897Q37198647-52F0CDEA-4A12-4CF2-BFDE-C7FDF9A53423Q38288391-1C7EB6CF-2630-4488-817D-AFE1C211F6BDQ38307253-68408372-77BB-4B39-84E2-2B861A399508Q38443771-9C6522C5-712A-4262-8602-97A3D0DABABAQ38705194-048D8445-FAF1-4F36-9A68-D07F8D22DD84Q38728260-3B31866E-8793-41C5-9983-E030227A98D2Q38773967-263A5895-55C6-4D76-A5F0-A54ED9D98658Q38826397-47DA6400-D7EA-4396-B629-2064863657C4Q38827049-94F8A741-F337-41DE-B972-0F6FBA82A3EFQ38915766-5F7DC958-87F0-4F33-9FDD-0881B6C56E4FQ38950332-1C398222-4C04-405C-BEBA-2CB9246ECA5EQ39334457-28E3008D-EC33-44EB-9054-AC30DDF343DAQ39426569-24A842D4-3925-440B-ADB2-D230A74E882EQ39815453-A22A3189-6CE7-4ECE-9728-D4601C54514EQ41104930-5FFDD673-5C8C-4A95-A9D5-9EDFA0ADD049Q41738775-57BED88C-2617-492E-80D5-07346C073A48Q41932504-A7FF5A47-8087-4107-8E58-0CED944A3E50Q42272163-1FA8FCB4-5334-465C-8780-4952AB65382DQ42716017-A2F1F5F9-498D-461C-ABBA-1C7DC1DD7E2DQ45973178-3BC28DCF-3E42-4D70-A5D4-A4BEF6143F7AQ46147646-35D204F1-ED81-4B7F-B809-C52AE3262423Q46157891-08139FFD-B8B3-4EA0-9C9B-F07491F26C21Q46572067-00CE39FF-4C78-48AA-AA63-B9DDE4970D2BQ47338184-FD5EE4B8-AC38-428C-A808-78D3F7718631Q52560094-6ADB80F0-2DD2-43BA-9B19-B51377D13A7FQ53695810-68B3E997-D789-4F61-9A33-837973F2957EQ58554042-105BDB39-53B9-483D-8DAB-A3E41CFE8E23Q71533642-BFF8B2C7-58C1-4E9D-ABB0-7E48E50A8D36Q73881026-E5B3FDA7-8813-45D0-B0DC-C7A7E1DEA0D3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Seok Ki Choi
@ast
Seok Ki Choi
@en
Seok Ki Choi
@es
Seok Ki Choi
@nl
Seok Ki Choi
@sl
type
label
Seok Ki Choi
@ast
Seok Ki Choi
@en
Seok Ki Choi
@es
Seok Ki Choi
@nl
Seok Ki Choi
@sl
prefLabel
Seok Ki Choi
@ast
Seok Ki Choi
@en
Seok Ki Choi
@es
Seok Ki Choi
@nl
Seok Ki Choi
@sl
P1053
A-2179-2014
P106
P1153
7408122970
P31
P3829
P496
0000-0001-5633-4817